BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35715138)

  • 1. Relevant Trials Update in Sarcomas and Gastrointestinal Stromal Tumors: What Surgeons Should Know.
    Callegaro D; Roland CL; Raut CP
    Surg Oncol Clin N Am; 2022 Jul; 31(3):341-360. PubMed ID: 35715138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the Current Management of Soft-tissue Sarcoma and Gastrointestinal Stromal Tumors and Emerging Directions.
    Dossa F; Gladdy RA
    Surg Oncol Clin N Am; 2023 Jan; 32(1):169-184. PubMed ID: 36410916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours.
    Mir O; Azaro A; Merchan J; Chugh R; Trent J; Rodon J; Ohnmacht U; Diener JT; Smith C; Yuen E; Oakley GJ; Le Cesne A; Soria JC; Benhadji KA; Massard C
    Eur J Cancer; 2018 Nov; 103():88-97. PubMed ID: 30218977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.
    Fontebasso AM; Rytlewski JD; Blay JY; Gladdy RA; Wilky BA
    Surg Oncol Clin N Am; 2024 Apr; 33(2):387-408. PubMed ID: 38401916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma.
    Zhao R; Yu X; Feng Y; Wang J; Mao Y; Yin W; Zhang Z; Guo X; Ma S
    Jpn J Clin Oncol; 2018 Sep; 48(9):799-805. PubMed ID: 30060202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].
    Malerba M; Garofalo A
    Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma.
    Mack T; Purgina B
    Curr Oncol; 2022 Sep; 29(9):6400-6418. PubMed ID: 36135073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft tissue sarcoma and radiation therapy advances, impact on toxicity.
    El-Bared N; Wong P; Wang D
    Curr Treat Options Oncol; 2015 May; 16(5):19. PubMed ID: 25859829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.
    Gamboa AC; Gronchi A; Cardona K
    CA Cancer J Clin; 2020 May; 70(3):200-229. PubMed ID: 32275330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local management of adult soft tissue sarcomas.
    Swallow CJ; Catton CN
    Semin Oncol; 2007 Jun; 34(3):256-69. PubMed ID: 17560988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
    Koseła-Paterczyk H; Rutkowski P
    Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soft tissue sarcomas and gastrointestinal stromal tumors].
    Reichardt P
    Internist (Berl); 2016 Mar; 57(3):245-56. PubMed ID: 26907871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)
    Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY
    Ann Oncol; 2021 Apr; 32(4):533-541. PubMed ID: 33482247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy in sarcomas other than GIST tumors.
    Sborov D; Chen JL
    J Surg Oncol; 2015 Apr; 111(5):632-40. PubMed ID: 25330750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcoma.
    Gyorki DE; Choong PFM; Slavin J; Henderson MA
    ANZ J Surg; 2018 Apr; 88(4):274-277. PubMed ID: 28768365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair.
    Boichuk S; Bikinieva F; Nurgatina I; Dunaev P; Valeeva E; Aukhadieva A; Sabirov A; Galembikova A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic therapy of soft tissue sarcomas].
    Pink D; Bertz-Lepel J; Reichardt P
    Pathologe; 2011 Feb; 32(1):65-71. PubMed ID: 21053001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal and visceral sarcomas: issues for the general surgeon.
    Woodall CE; Scoggins CR
    Am Surg; 2007 Jun; 73(6):631-5. PubMed ID: 17658103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in the management of adult soft tissue sarcomas.
    Kneisl JS; Coleman MM; Raut CP
    J Surg Oncol; 2014 Oct; 110(5):527-38. PubMed ID: 24965077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma.
    Judson I; Scurr M; Gardner K; Barquin E; Marotti M; Collins B; Young H; Jürgensmeier JM; Leahy M
    Clin Cancer Res; 2014 Jul; 20(13):3603-12. PubMed ID: 24714778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.